Board of Directors and
Board of Commissioners
Indonesian citizen, born in 1965. He has served as the President Director of the Company since 2022.
He began his career as a System Analyst at Landis and Gyrs System Corporation, USA (1989-1991), and as a Manufacturing and Business Consultant at Oracle Corporation, USA (1991-1994). He entered the healthcare industry in 2006, with his most recent position being the President Director of Ferron Par Pharmaceutical (2016-2022). He currently also serves as a Director at Sarana Titan Manunggal.
He represents the Indonesian Chamber of Commerce and Industry (KADIN), serves as the Deputy Chairman of the Permanent Committee on Pharmaceutical and Medical Device Industries at KADIN, and sits on the National Team Working Group for Increasing Domestic Product Utilization. He is also the Chairman of the Indonesian Pharmaceutical Companies Association, Jakarta, and Chairman of the International Society for Pharmaceutical Engineering (ISPE), the largest non-profit association in the pharmaceutical field.
He holds a Bachelor’s Degree in Electrical Engineering from the University of Washington, USA (1988), a Master’s Degree in Electrical Engineering & Computer Science from the University of Southern California, USA (1989), and has completed the Advanced Finance Program at The Wharton School, University of Pennsylvania (2019-2021).
Krestijanto Pandji
President Director
Indonesian citizen, born in 1971. He has served as a Director of the Company since 2020.
He joined the Company and its subsidiaries in 1999 as Deputy Branch Head and has since held various positions at Anugrah Argon Medica (AAM), with his last position being Head of Business & Infrastructure (1998-2010). He is currently also a Commissioner of AAM and a Director of Djembatan Dua.
He holds a Bachelor's degree in Civil Engineering from the Surabaya Institute of Technology (1996) and a Master's degree in Management from the PPM School of Management (formerly LPPM) (1998).
Edbert Orotodan
Director
Indonesian citizen, born in 1955. He has served as a Director of the Company since 2022.
He began his career working at IBM Indonesia, holding various positions with his last role being Director of Operations (1979-1998). He continued his career as Operations Executive at IBM Asia Pacific (1998-2004). In 2005, he joined Dexa Group as Corporate Chief Information Officer of Dexa Medica (2005-2010). He served as President Director of Dexa Medica from 2017 to 2021. He is currently also serving as Director of Equilab International, Commissioner of Global Urban Esensial, and Karsa Inti Tuju Askara.
He holds a Bachelor's degree in Communication Electronics from the University of Indonesia (1979) and a Master's degree in Applied Finance from Macquarie University, Australia (2007).
Wimala Widjaja
Director
Board of Directors
Indonesian citizen, born in 1961. He has served as a Commissioner of the Company since 2020.
He began his career as a doctor at Atma Jaya Hospital, Jakarta (1989-1991), and continued his career at PT Organon Teknika Indonesia, with his last position being General Manager (1993-1999). He then worked at PT Antar Mitra Sembaga as General Manager Marketing (2000-2002) and at PT BSN Medical Indonesia, with his last position being Regional Director Emerging Market East Asia (2002-2015). He is currently also serving as Commissioner of PT Djembatan Dua and PT Deca Metric Medica.
He holds a Bachelor's degree in Medicine from Atma Jaya Catholic University of Indonesia (1988).
Stanley Ch. Budihardja
President Commissioner
An Indonesian citizen, born in 1964. He has served as an Independent Commissioner of the Company since 2024.
He began his career as a Full-time Lecturer at Atma Jaya University Yogyakarta (1988-2000) and later continued as a Part-time Lecturer at the Indonesian Institute for Management Development (1998-2000), Assistant Lecturer at Monash University & Deakin University, Australia (2005-2007), Vice Chairman for Research at the Indonesian Institute for Corporate Directorship (2017-2023), Independent Commissioner of PT Prodia Widyahusada Tbk (2017-2021), and Advisor to the Board of Commissioners and Directors of PT Taman Safari Indonesia Group (2020-2022). Currently, he also serves as a Full-time Lecturer at Prasetiya Mulya University since 2001.
He holds a Bachelor's degree in Economics, majoring in Management, from Atma Jaya University Yogyakarta (1987), a Master of Science degree in Finance, Banking, and Investment from the University of Wisconsin, United States (1992), and a Ph.D. in Banking & Finance from Monash University, Australia (2007).
Lukas Setia Atmaja, M.Sc.
Independent Commissioner
Board of Commissioners